Strategy and Progress
Phase 1
Intervention Development, Clinical Trial, and Cultural Adaptation Framework
Phase 2
Monitoring & Evaluation Measures, and Market-Ready Technology
Phase 3
Scale
PHASE 1
✅ Community-informed curriculum (N=7,340),
✅ Controlled clinical trial with refugees (N=70).
✅ Field and research minimum viable products.
✅ Pilot implementation (N=100) in a low-resource Ebola-impacted setting in Liberia, West Africa.
✅ Cultural adaptation framework research.
✅ First cultural adaptation (Ukrainian).
PHASE 2
✅ Validation of a subjective transdiagnostic trauma screener for refugees.
Present activity
➡ Digital platform and media production for eResilience Ukraine.
Upcoming
➡ Launch the eResilience Ukraine platform for preliminary implementation.
➡ Resource mobilization for new target populations including Liberians, Congolese, Sudanese, Palestinians, Burmese, Brazilians and Venezuelans.
➡ Validation research of combined objective and subjective monitoring and evaluation (M&E) measures among Ukrainians.
➡ Digital platform and media production for new versions.
➡ Test and iterate M&Es to platforms.
➡ Market-ready eResilience digital platforms.
PHASE 3
We aim to commence scaling in target locations concurrent with ongoing clinical research (funding permitting), led by renowned trauma experts to examine and monitor challenges, intervention efficacy and safety at scale.
News and Updates
News & Updates